Thomas Schall
Director/Board Member bei IMMUNEERING CORPORATION
Vermögen: 8 381 $ am 31.03.2024
Profil
Thomas J.
Schall is the founder of ChemoCentryx, Inc., a company founded in 1997.
He held the title of Chairman, President & Chief Executive Officer from 2012 to 2022.
Dr. Schall is currently working as a Director at Immuneering Corp.
since 2024.
In the past, he worked as a Scientist at Genentech, Inc. and as a Principal at DNAX Research, Inc. Dr. Schall obtained a doctorate degree from Stanford University and an undergraduate degree from Northern Illinois University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.03.2024 | 2 900 ( 0,01% ) | 8 381 $ | 31.03.2024 |
Aktive Positionen von Thomas Schall
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNEERING CORPORATION | Director/Board Member | 12.03.2024 |
Ehemalige bekannte Positionen von Thomas Schall
| Unternehmen | Position | Ende |
|---|---|---|
| CHEMOCENTRYX, INC. | Chief Executive Officer | 20.10.2022 |
| DNAX Research, Inc. | Corporate Officer/Principal | 01.01.1997 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Thomas Schall
| Stanford University | Doctorate Degree |
| Northern Illinois University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IMMUNEERING CORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
| DNAX Research, Inc. |
